These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24886852)

  • 61. Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.
    Gladstone E; Smolina K; Morgan SG; Fernandes KA; Martins D; Gomes T
    CMAJ; 2016 Mar; 188(4):E67-E72. PubMed ID: 26622006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions.
    Fischer B; Robinson T; Jutras-Aswad D
    Drug Alcohol Rev; 2024 Feb; 43(2):562-566. PubMed ID: 38098180
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.
    Jones W; Kurdyak P; Fischer B
    BMC Health Serv Res; 2020 Jul; 20(1):677. PubMed ID: 32698815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents.
    Carmona J; Maxwell JC; Park JY; Wu LT
    J Adolesc Health; 2020 May; 66(5):536-544. PubMed ID: 31964613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.
    Tadrous M; Greaves S; Martins D; Nadeem K; Singh S; Mamdani MM; Juurlink DN; Gomes T
    Int J Drug Policy; 2019 Apr; 66():82-86. PubMed ID: 30743092
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioids in Canada.
    Grywacheski V; Sabad A; Kushtova L; Bender M; Rennie N; Cheng R; Louie K
    Healthc Q; 2019 Apr; 22(1):11-13. PubMed ID: 31244462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivation.
    Ellis MS; Cicero TJ; Dart RC; Green JL
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):117-121. PubMed ID: 30411819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
    Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
    Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A public health outbreak management framework applied to surges in opioid overdoses.
    Moore K; Boulet M; Lew J; Papadomanolakis-Pakis N
    J Opioid Manag; 2017; 13(5):273-281. PubMed ID: 29199393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trends and key correlates of prescription opioid injection misuse in the United States.
    Jones CM
    Addict Behav; 2018 Mar; 78():145-152. PubMed ID: 29175290
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.
    Bonar EE; Coughlin L; Roche JS; Philyaw-Kotov ML; Bixler EA; Sinelnikov S; Kolosh A; Cihak MJ; Cunningham RM; Walton MA
    Prev Med; 2020 Mar; 132():105972. PubMed ID: 31904397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses.
    Goldner EM; Lusted A; Roerecke M; Rehm J; Fischer B
    Addict Behav; 2014 Mar; 39(3):520-31. PubMed ID: 24333033
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prescription opioid abuse in the UK.
    Giraudon I; Lowitz K; Dargan PI; Wood DM; Dart RC
    Br J Clin Pharmacol; 2013 Nov; 76(5):823-4. PubMed ID: 23594290
    [No Abstract]   [Full Text] [Related]  

  • 75. Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users.
    Fischer B; Patra J; Cruz MF; Gittins J; Rehm J
    Drug Alcohol Rev; 2008 Nov; 27(6):625-32. PubMed ID: 19378446
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prescription opioid misuse among heterosexual versus lesbian, gay, and bisexual military veterans: Evidence from the 2015-2017 national survey of drug use and health.
    Anderson-Carpenter KD; Rutledge JD; Mitchell K
    Drug Alcohol Depend; 2020 Feb; 207():107794. PubMed ID: 31864165
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
    Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
    JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.